中国基层医疗机构抗生素管理策略的挑战与对策
Challenges and Countermeasures of Antibiotic Management Strategy in Primary Medical Institutions in China
DOI: 10.12677/acm.2025.15102953, PDF,   
作者: 哈斯铁尔·塔尔提甫汗:阿勒泰地区中医医院(阿勒泰地区哈萨克医医院)药剂科,新疆 阿勒泰
关键词: 抗生素使用不当细菌耐药性多重耐药菌合理用药对策Antibiotics Improper Use Bacterial Resistance Multidrug-Resistant Bacteria Rational Drug Use Countermeasures
摘要: 抗生素的发现与应用是人类医学史上的里程碑,显著降低了细菌感染性疾病的死亡率。然而,全球范围内普遍存在的抗生素使用不当问题,正导致耐药菌株的迅猛产生与传播,严重威胁公共健康安全。中国基层医疗机构作为群众看病就医的首站,其抗生素使用是否合理,直接关系到国家遏制细菌耐药战略的成败。本文旨在聚焦中国基层医疗机构,系统分析其抗生素使用不当的主要现象与深层原因,重点剖析其在人员能力、诊断条件、监管落实等方面面临的特殊挑战,并在此基础上提出以“强化AMS模式本土化、提升快速诊断可及性、创新监管与激励方式”为核心的针对性对策,以期为提升基层抗生素合理用药水平、有效应对细菌耐药性挑战提供参考。
Abstract: The discovery and application of antibiotics represent a milestone in the history of human medicine, significantly reducing the mortality rate of bacterial infectious diseases. However, the widespread misuse of antibiotics globally is leading to the rapid emergence and spread of drug-resistant strains, posing a serious threat to public health security. Primary healthcare institutions in China, as the first point of contact for patients seeking medical care, play a crucial role in the rational use of antibiotics, which directly affects the success of the national strategy to contain bacterial resistance. This paper aims to focus on primary healthcare institutions in China, systematically analyze the main manifestations and underlying causes of improper antibiotic use, and delve into the specific challenges faced in terms of personnel capability, diagnostic conditions, and regulatory implementation. Based on this analysis, targeted strategies are proposed, centered on “strengthening the localization of Antimicrobial Stewardship (AMS) programs, enhancing the accessibility of rapid diagnostics, and innovating regulatory and incentive mechanisms”, to improve the rational use of antibiotics at the grassroots level and effectively address the challenge of bacterial resistance.
文章引用:哈斯铁尔·塔尔提甫汗. 中国基层医疗机构抗生素管理策略的挑战与对策[J]. 临床医学进展, 2025, 15(10): 1842-1846. https://doi.org/10.12677/acm.2025.15102953

参考文献

[1] World Health Organization (2023) Antibiotic Resistance.
https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance
[2] O’Neill, J. (2016) Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. The Review on Antimicrobial Resistance.
[3] 李大川, 杨帆, 肖永红, 等. 我国抗菌药物临床应用监测与管理成效分析[J]. 中华医院感染学杂志, 2021, 31(10): 1441-1445.
[4] Llor, C. and Bjerrum, L. (2014) Antimicrobial Resistance: Risk Associated with Antibiotic Overuse and Initiatives to Reduce the Problem. Therapeutic Advances in Drug Safety, 5, 229-241. [Google Scholar] [CrossRef] [PubMed]
[5] Van Boeckel, T.P., Brower, C., Gilbert, M., Grenfell, B.T., Levin, S.A., Robinson, T.P., et al. (2015) Global Trends in Antimicrobial Use in Food Animals. Proceedings of the National Academy of Sciences, 112, 5649-5654. [Google Scholar] [CrossRef] [PubMed]
[6] Plebani, M., Sciacovelli, L., Aita, A., Pelloso, M. and Chiozza, M.L. (2015) Performance Criteria and Quality Indicators for the Pre-Analytical Phase. Clinical Chemistry and Laboratory Medicine (CCLM), 53, 943-948. [Google Scholar] [CrossRef] [PubMed]
[7] Grigoryan, L., Germanos, G., Zoorob, R., Juneja, S., Raphael, J.L., Paasche-Orlow, M.K., et al. (2019) Use of Antibiotics without a Prescription in the U.S. Population: A Scoping Review. Annals of Internal Medicine, 171, 257-263. [Google Scholar] [CrossRef] [PubMed]
[8] 钟南山. 抗菌药物临床应用中的问题与对策[J]. 中华结核和呼吸杂志, 2011, 34(1): 3-4.
[9] Xue, H., Shi, Y., Huang, L., et al. (2020) Drivers of Inappropriate Antibiotic Prescribing in Primary Care in China: A Mixed-Methods Systematic Review. BMJ Global Health, 5, e003599.
[10] Wang, J., Wang, P., Wang, X., Zheng, Y. and Xiao, Y. (2014) Use and Prescription of Antibiotics in Primary Health Care Settings in China. JAMA Internal Medicine, 174, 1914-1920. [Google Scholar] [CrossRef] [PubMed]
[11] Huang, Y., Gu, J., Zhang, M., Ren, Z., Yang, W., Chen, Y., et al. (2013) Knowledge, Attitude and Practice of Antibiotics: A Questionnaire Study among 2500 Chinese Students. BMC Medical Education, 13, Article No. 163. [Google Scholar] [CrossRef] [PubMed]
[12] 国家卫生健康委员会. 遏制细菌耐药国家行动计划(2022-2025年) [Z]. 2022.
[13] Xie, D., Xiang, N., Hu, Q., et al. (2021) A Survey of the Implementation of Antimicrobial Stewardship Programs in Tertiary Hospitals in China. Infection and Drug Resistance, 14, Article 5013.
[14] Roope, L.S.J., Smith, R.D., Pouwels, K.B., Buchanan, J., Abel, L., Eibich, P., et al. (2019) The Challenge of Antimicrobial Resistance: What Economics Can Contribute. Science, 364, eaau4679. [Google Scholar] [CrossRef] [PubMed]
[15] 国家卫生计生委办公厅. 抗菌药物临床应用管理办法[J]. 中国医药导刊, 2012, 34(1): 3-4.
[16] Tang, K.L., Caffrey, N.P., Nóbrega, D.B., Cork, S.C., Ronksley, P.E., Barkema, H.W., et al. (2017) Restricting the Use of Antibiotics in Food-Producing Animals and Its Associations with Antibiotic Resistance in Food-Producing Animals and Human Beings: A Systematic Review and Meta-Analysis. The Lancet Planetary Health, 1, e316-e327. [Google Scholar] [CrossRef] [PubMed]
[17] Barlam, T.F., Cosgrove, S.E., Abbo, L.M., MacDougall, C., Schuetz, A.N., Septimus, E.J., et al. (2016) Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases, 62, e51-e77. [Google Scholar] [CrossRef] [PubMed]
[18] 肖永红, 沈萍, 杨帆. 抗菌药物科学化管理实践[J]. 中国感染控制杂志, 2018, 17(1): 1-6.
[19] WHO (2015) Global Action Plan on Antimicrobial Resistance.
[20] Theuretzbacher, U., Outterson, K., Engel, A. and Karlén, A. (2020) The Global Preclinical Antibacterial Pipeline. Nature Reviews Microbiology, 18, 275-285. [Google Scholar] [CrossRef] [PubMed]